Lista de obras -

A rapid ELISA for the diagnosis of MB leprosy based on complementary detection of antibodies against a novel protein-glycolipid conjugate.

artículo científico publicado en 2014

A synthetic adjuvant to enhance and expand immune responses to influenza vaccines

artículo científico publicado en 2010

Accurate Serodetection of Asymptomatic Leishmania donovani Infection by Use of Defined Antigens

artículo científico publicado en 2016

Adjuvants

scientific article published on 25 July 2018

Adjuvants for Leishmania vaccines: from models to clinical application ⬇️

artículo científico publicado el 11 de junio de 2012

Advances and hurdles on the way toward a leprosy vaccine ⬇️

artículo científico publicado el 1 de noviembre de 2011

Advances toward Diagnostic Tools for Managing Zoonotic Visceral Leishmaniasis

artículo científico publicado en 2018

Alteration of the serum biomarker profiles of visceral leishmaniasis during treatment

scientific article published on 31 October 2013

Alterations to antigen-specific immune responses before and after multidrug therapy of leprosy.

artículo científico publicado en 2015

Analysis of antibody responses to Mycobacterium leprae phenolic glycolipid I, lipoarabinomannan, and recombinant proteins to define disease subtype-specific antigenic profiles in leprosy.

artículo científico publicado en 2010

Anti-natural octyl disaccharide-leprosy IDRI diagnostic (NDO-LID) antibodies as indicators of leprosy reactions and neuritis.

artículo científico publicado en 2017

Antigen-specific T-cell responses of leprosy patients

artículo científico publicado en 2008

Antigen-specific secretion of IFNγ and CXCL10 in whole blood assay detects Mycobacterium leprae infection but does not discriminate asymptomatic infection from symptomatic leprosy.

artículo científico publicado en 2017

Application of Mycobacterium Leprae-specific cellular and serological tests for the differential diagnosis of leprosy from confounding dermatoses.

artículo científico publicado en 2016

Applying TLR synergy in immunotherapy: implications in cutaneous leishmaniasis.

artículo científico publicado en 2010

Assessing epidemiology of leprosy and socio-economic distribution of cases

artículo científico publicado en 2018

Biomarkers for intracellular pathogens: establishing tools as vaccine and therapeutic endpoints for visceral leishmaniasis

artículo científico publicado en 2013

Both CD1d antigen presentation and interleukin-12 are required to activate natural killer T cells during Trypanosoma cruzi infection

artículo científico publicado en 2005

Clinical and epidemiological indicators and spatial analysis of leprosy cases in patients under 15 years old in an endemic area of Northeast Brazil: an ecological and time series study

artículo científico publicado en 2019

Combination chemoprophylaxis and immunoprophylaxis in reducing the incidence of leprosy

artículo científico publicado en 2016

Comparative evaluation of antibody detection tests to facilitate the diagnosis of multibacillary leprosy

artículo científico publicado en 2016

Comparison of Enzyme-Linked Immunosorbent Assay Using Either Natural Octyl Disaccharide-Leprosy IDRI Diagnostic or Phenolic Glycolipid-I Antigens for the Detection of Leprosy Patients in Colombia.

artículo científico publicado en 2017

Computationally Designed Bispecific MD2/CD14 Binding Peptides Show TLR4 Agonist Activity

artículo científico publicado en 2018

Correlates of GLA family adjuvants' activities

artículo científico publicado en 2018

Could canine visceral leishmaniosis take hold in the UK?

scientific article published on 01 April 2019

Critical proinflammatory and anti-inflammatory functions of different subsets of CD1d-restricted natural killer T cells during Trypanosoma cruzi infection.

artículo científico publicado en 2005

Development and characterization of synthetic glucopyranosyl lipid adjuvant system as a vaccine adjuvant

artículo científico publicado en 2011

Development and pre-clinical assessment of a 73 kD chimeric fusion protein as a defined sub-unit vaccine for leprosy.

artículo científico publicado en 2012

Development of a high density hemagglutinin protein microarray to determine the breadth of influenza antibody responses

artículo científico publicado en 2013

Development of a mouse food pad model for detection of sub clinical leprosy

artículo científico publicado en 2011

Development of a quantitative rapid diagnostic test for multibacillary leprosy using smart phone technology.

artículo científico publicado en 2013

Differential effects of UVA1 and UVB radiation on Langerhans cell migration in mice

scientific article published on 01 September 2000

Differential immunoglobulin and complement levels in leprosy prior to development of reversal reaction and erythema nodosum leprosum

artículo científico publicado en 2019

Distinct Roles of Th17 and Th1 Cells in Inflammatory Responses Associated with the Presentation of Paucibacillary Leprosy and Leprosy Reactions

artículo científico publicado en 2017

During acute Trypanosoma cruzi infection highly susceptible mice deficient in natural killer cells are protected by a single alpha-galactosylceramide treatment

artículo científico publicado en 2006

DuringTrypanosoma cruziInfection CD1d-Restricted NK T Cells Limit Parasitemia and Augment the Antibody Response to a Glycophosphoinositol-Modified Surface Protein ⬇️

artículo científico publicado el 1 de enero de 2002

Early Revelation of Leprosy in China by Sequential Antibody Analyses with LID-1 and PGL-I ⬇️

artículo científico publicado el 28 de enero de 2013

Evaluation of diagnostic performance of rK28 ELISA using urine for diagnosis of visceral leishmaniasis

artículo científico publicado en 2016

Evaluation of novel tools to facilitate the detection and characterization of leprosy patients in China

artículo científico publicado en 2014

Evaluation of various cytokines elicited during antigen-specific recall as potential risk indicators for the differential development of leprosy ⬇️

artículo científico publicado el 12 de noviembre de 2011

High levels of soluble CD40 ligand and matrix metalloproteinase-9 in serum are associated with favorable clinical evolution in human visceral leishmaniasis.

artículo científico publicado en 2013

IL-18 and Subcapsular Lymph Node Macrophages are Essential for Enhanced B Cell Responses with TLR4 Agonist Adjuvants.

artículo científico publicado en 2016

Identification of serological biomarkers of infection, disease progression and treatment efficacy for leprosy

scientific article published in 2012

Identifying Leprosy and Those at Risk of Developing Leprosy by Detection of Antibodies against LID-1 and LID-NDO

artículo científico publicado en 2016

Immunologically reactive M. leprae antigens with relevance to diagnosis and vaccine development

artículo científico publicado en 2011

Immunomodulatory and physical effects of oil composition in vaccine adjuvant emulsions.

artículo científico publicado en 2011

Immunomodulatory and physical effects of phospholipid composition in vaccine adjuvant emulsions.

artículo científico publicado en 2012

Impact of sequelae of visceral leishmaniasis and their contribution to ongoing transmission of Leishmania donovani

artículo científico publicado en 2019

Insight toward early diagnosis of leprosy through analysis of the developing antibody responses of Mycobacterium leprae-infected armadillos.

artículo científico publicado en 2010

Integrative literature review of the reported uses of serological tests in leprosy management

artículo científico publicado en 2016

Interleukin 17A acts synergistically with interferon γ to promote protection against Leishmania infantum infection

artículo científico publicado en 2014

LepVax, a defined subunit vaccine that provides effective pre-exposure and post-exposure prophylaxis of M. leprae infection.

artículo científico publicado en 2018

Micronutrients influencing the immune response in leprosy

artículo científico publicado en 2014

Multi-epitope proteins for improved serological detection of Trypanosoma cruzi infection and Chagas Disease.

artículo científico publicado en 2015

Multibacillary leprosy patients with high and persistent serum antibodies to leprosy IDRI diagnostic-1/LID-1: higher susceptibility to develop type 2 reactions.

artículo científico publicado en 2015

Need for, and acceptability of, rapid diagnostic tests that can facilitate the diagnosis of leprosy

scientific article published on 01 June 2016

Nitazoxanide is active against Mycobacterium leprae.

artículo científico

Not All Antigens Are Created Equally: Progress, Challenges, and Lessons Associated with Developing a Vaccine for Leishmaniasis.

artículo científico publicado en 2017

Optimizing Immunization Strategies for the Induction of Antigen-Specific CD4 and CD8 T Cell Responses for Protection against Intracellular Parasites.

scientific article published on 27 July 2016

Optimizing manufacturing and composition of a TLR4 nanosuspension: physicochemical stability and vaccine adjuvant activity

scientific article published on 21 December 2013

Protection of mice from Mycobacterium tuberculosis by ID87/GLA-SE, a novel tuberculosis subunit vaccine candidate.

artículo científico publicado en 2011

Rapid quantitative serological test for detection of infection with Mycobacterium leprae, the causative agent of leprosy

artículo científico publicado en 2013

Rational design and evaluation of a multiepitope chimeric fusion protein with the potential for leprosy diagnosis

artículo científico publicado en 2009

Real-time PCR in detection and quantitation of Leishmania donovani for the diagnosis of Visceral Leishmaniasis patients and the monitoring of their response to treatment

artículo científico publicado en 2017

Recovery of antigen-specific T cell responses from dogs infected with Leishmania (L.) infantum by use of vaccine associated TLR-agonist adjuvant.

artículo científico publicado en 2016

Screening and identification of immunoactive peptide mimotopes for the enhanced serodiagnosis of tuberculosis

artículo científico publicado en 2015

Second coming: the re-emergence and modernization of immunotherapy by vaccines as a component of leprosy control

artículo científico publicado en 2018

Selection of antigens and development of prototype tests for point-of-care leprosy diagnosis.

artículo científico publicado en 2008

Semi-quantitative measurement of asymptomatic L. infantum infection and symptomatic visceral leishmaniasis in dogs using Dual-Path Platform® CVL.

artículo científico publicado en 2016

Serologic follow-up of IgG responses against recombinant mycobacterial proteins ML0405, ML2331 and LID-1 in a leprosy hyperendemic area in Venezuela

artículo científico publicado en 2012

Serological characterizations of tandem repeat proteins for detection of African trypanosome infection in cattle.

artículo científico publicado en 2011

Seroreactivity to new Mycobacterium leprae protein antigens in different leprosy-endemic regions in Brazil.

artículo científico publicado en 2012

Social and environmental conditions related to Mycobacterium leprae infection in children and adolescents from three leprosy endemic regions of Colombia

scientific article published on 13 June 2019

Specific IgG antibody responses may be used to monitor leprosy treatment efficacy and as recurrence prognostic markers

article

Specific antibody responses as indicators of treatment efficacy for visceral leishmaniasis.

artículo científico publicado en 2014

Squalene emulsion potentiates the adjuvant activity of the TLR4 agonist, GLA, via inflammatory caspases, IL-18, and IFN-γ.

artículo científico publicado en 2014

Synergistic antigen combinations for the development of interferon gamma release assays for paucibacillary leprosy.

artículo científico publicado en 2014

The development and clinical evaluation of second-generation leishmaniasis vaccines.

artículo científico publicado en 2011

The effects of ultraviolet radiation on the human immune system.

artículo científico publicado en 1999

The potential for vaccination in leprosy elimination: new tools for targeted interventions.

artículo científico publicado en 2012

Treatment with alpha-galactosylceramide before Trypanosoma cruzi infection provides protection or induces failure to thrive

scientific article published on 01 June 2002

Trypanosoma cruzi-infected individuals demonstrate varied antibody responses to a panel of trans-sialidase proteins encoded by SA85-1 genes

article

Tuberculosis and leprosy infections in the Marshallese population of Arkansas, USA.

artículo científico publicado en 2016

Unexpectedly high leprosy seroprevalence detected using a random surveillance strategy in midwestern Brazil: A comparison of ELISA and a rapid diagnostic test

artículo científico publicado en 2017

Use of defined TLR ligands as adjuvants within human vaccines.

artículo científico publicado en 2011

Utility and limitations of serodiagnostic tests in monitoring the response to treatment of leprosy patients

scientific article published on 03 January 2020

Utility of recombinant proteins LID-1 and PADL in screening for Mycobacterium leprae infection and leprosy.

artículo científico publicado en 2014

Vaccination with the Surface Proteins MUL_2232 and MUL_3720 of Mycobacterium ulcerans Induces Antibodies but Fails to Provide Protection against Buruli Ulcer.

artículo científico publicado en 2016

Vaccines for leishmaniasis and the implications of their development for American tegumentary leishmaniasis

scientific article published on 11 November 2019

Zoonotic Leprosy in the Southeastern United States

artículo científico publicado en 2015

sCD163 levels as a biomarker of disease severity in leprosy and visceral leishmaniasis

artículo científico publicado en 2017

Lista de obras de

A rapid ELISA for the diagnosis of MB leprosy based on complementary detection of antibodies against a novel protein-glycolipid conjugate.

A synthetic adjuvant to enhance and expand immune responses to influenza vaccines

Accurate Serodetection of Asymptomatic Leishmania donovani Infection by Use of Defined Antigens

Adjuvants

Adjuvants for Leishmania vaccines: from models to clinical application ⬇️

Advances and hurdles on the way toward a leprosy vaccine ⬇️

Advances toward Diagnostic Tools for Managing Zoonotic Visceral Leishmaniasis

Alteration of the serum biomarker profiles of visceral leishmaniasis during treatment

Alterations to antigen-specific immune responses before and after multidrug therapy of leprosy.

Analysis of antibody responses to Mycobacterium leprae phenolic glycolipid I, lipoarabinomannan, and recombinant proteins to define disease subtype-specific antigenic profiles in leprosy.

Anti-natural octyl disaccharide-leprosy IDRI diagnostic (NDO-LID) antibodies as indicators of leprosy reactions and neuritis.

Antigen-specific T-cell responses of leprosy patients

Antigen-specific secretion of IFNγ and CXCL10 in whole blood assay detects Mycobacterium leprae infection but does not discriminate asymptomatic infection from symptomatic leprosy.

Application of Mycobacterium Leprae-specific cellular and serological tests for the differential diagnosis of leprosy from confounding dermatoses.

Applying TLR synergy in immunotherapy: implications in cutaneous leishmaniasis.

Assessing epidemiology of leprosy and socio-economic distribution of cases

Biomarkers for intracellular pathogens: establishing tools as vaccine and therapeutic endpoints for visceral leishmaniasis

Both CD1d antigen presentation and interleukin-12 are required to activate natural killer T cells during Trypanosoma cruzi infection

Clinical and epidemiological indicators and spatial analysis of leprosy cases in patients under 15 years old in an endemic area of Northeast Brazil: an ecological and time series study

Combination chemoprophylaxis and immunoprophylaxis in reducing the incidence of leprosy

Comparative evaluation of antibody detection tests to facilitate the diagnosis of multibacillary leprosy

Comparison of Enzyme-Linked Immunosorbent Assay Using Either Natural Octyl Disaccharide-Leprosy IDRI Diagnostic or Phenolic Glycolipid-I Antigens for the Detection of Leprosy Patients in Colombia.

Computationally Designed Bispecific MD2/CD14 Binding Peptides Show TLR4 Agonist Activity

Correlates of GLA family adjuvants' activities

Could canine visceral leishmaniosis take hold in the UK?

Critical proinflammatory and anti-inflammatory functions of different subsets of CD1d-restricted natural killer T cells during Trypanosoma cruzi infection.

Development and characterization of synthetic glucopyranosyl lipid adjuvant system as a vaccine adjuvant

Development and pre-clinical assessment of a 73 kD chimeric fusion protein as a defined sub-unit vaccine for leprosy.

Development of a high density hemagglutinin protein microarray to determine the breadth of influenza antibody responses

Development of a mouse food pad model for detection of sub clinical leprosy

Development of a quantitative rapid diagnostic test for multibacillary leprosy using smart phone technology.

Differential effects of UVA1 and UVB radiation on Langerhans cell migration in mice

Differential immunoglobulin and complement levels in leprosy prior to development of reversal reaction and erythema nodosum leprosum

Distinct Roles of Th17 and Th1 Cells in Inflammatory Responses Associated with the Presentation of Paucibacillary Leprosy and Leprosy Reactions

During acute Trypanosoma cruzi infection highly susceptible mice deficient in natural killer cells are protected by a single alpha-galactosylceramide treatment

DuringTrypanosoma cruziInfection CD1d-Restricted NK T Cells Limit Parasitemia and Augment the Antibody Response to a Glycophosphoinositol-Modified Surface Protein ⬇️

Early Revelation of Leprosy in China by Sequential Antibody Analyses with LID-1 and PGL-I ⬇️

Evaluation of diagnostic performance of rK28 ELISA using urine for diagnosis of visceral leishmaniasis

Evaluation of novel tools to facilitate the detection and characterization of leprosy patients in China

Evaluation of various cytokines elicited during antigen-specific recall as potential risk indicators for the differential development of leprosy ⬇️

High levels of soluble CD40 ligand and matrix metalloproteinase-9 in serum are associated with favorable clinical evolution in human visceral leishmaniasis.

IL-18 and Subcapsular Lymph Node Macrophages are Essential for Enhanced B Cell Responses with TLR4 Agonist Adjuvants.

Identification of serological biomarkers of infection, disease progression and treatment efficacy for leprosy

Identifying Leprosy and Those at Risk of Developing Leprosy by Detection of Antibodies against LID-1 and LID-NDO

Immunologically reactive M. leprae antigens with relevance to diagnosis and vaccine development

Immunomodulatory and physical effects of oil composition in vaccine adjuvant emulsions.

Immunomodulatory and physical effects of phospholipid composition in vaccine adjuvant emulsions.

Impact of sequelae of visceral leishmaniasis and their contribution to ongoing transmission of Leishmania donovani

Insight toward early diagnosis of leprosy through analysis of the developing antibody responses of Mycobacterium leprae-infected armadillos.

Integrative literature review of the reported uses of serological tests in leprosy management

Interleukin 17A acts synergistically with interferon γ to promote protection against Leishmania infantum infection

LepVax, a defined subunit vaccine that provides effective pre-exposure and post-exposure prophylaxis of M. leprae infection.

Micronutrients influencing the immune response in leprosy

Multi-epitope proteins for improved serological detection of Trypanosoma cruzi infection and Chagas Disease.

Multibacillary leprosy patients with high and persistent serum antibodies to leprosy IDRI diagnostic-1/LID-1: higher susceptibility to develop type 2 reactions.

Need for, and acceptability of, rapid diagnostic tests that can facilitate the diagnosis of leprosy

Nitazoxanide is active against Mycobacterium leprae.

Not All Antigens Are Created Equally: Progress, Challenges, and Lessons Associated with Developing a Vaccine for Leishmaniasis.

Optimizing Immunization Strategies for the Induction of Antigen-Specific CD4 and CD8 T Cell Responses for Protection against Intracellular Parasites.

Optimizing manufacturing and composition of a TLR4 nanosuspension: physicochemical stability and vaccine adjuvant activity

Protection of mice from Mycobacterium tuberculosis by ID87/GLA-SE, a novel tuberculosis subunit vaccine candidate.

Rapid quantitative serological test for detection of infection with Mycobacterium leprae, the causative agent of leprosy

Rational design and evaluation of a multiepitope chimeric fusion protein with the potential for leprosy diagnosis

Real-time PCR in detection and quantitation of Leishmania donovani for the diagnosis of Visceral Leishmaniasis patients and the monitoring of their response to treatment

Recovery of antigen-specific T cell responses from dogs infected with Leishmania (L.) infantum by use of vaccine associated TLR-agonist adjuvant.

Screening and identification of immunoactive peptide mimotopes for the enhanced serodiagnosis of tuberculosis

Second coming: the re-emergence and modernization of immunotherapy by vaccines as a component of leprosy control

Selection of antigens and development of prototype tests for point-of-care leprosy diagnosis.

Semi-quantitative measurement of asymptomatic L. infantum infection and symptomatic visceral leishmaniasis in dogs using Dual-Path Platform® CVL.

Serologic follow-up of IgG responses against recombinant mycobacterial proteins ML0405, ML2331 and LID-1 in a leprosy hyperendemic area in Venezuela

Serological characterizations of tandem repeat proteins for detection of African trypanosome infection in cattle.

Seroreactivity to new Mycobacterium leprae protein antigens in different leprosy-endemic regions in Brazil.

Social and environmental conditions related to Mycobacterium leprae infection in children and adolescents from three leprosy endemic regions of Colombia

Specific IgG antibody responses may be used to monitor leprosy treatment efficacy and as recurrence prognostic markers

Specific antibody responses as indicators of treatment efficacy for visceral leishmaniasis.

Squalene emulsion potentiates the adjuvant activity of the TLR4 agonist, GLA, via inflammatory caspases, IL-18, and IFN-γ.

Synergistic antigen combinations for the development of interferon gamma release assays for paucibacillary leprosy.

The development and clinical evaluation of second-generation leishmaniasis vaccines.

The effects of ultraviolet radiation on the human immune system.